Neurofibromatosis type 1 is an autosomal dominant genetic disease and a common tumor predisposition syndrome that affects one in 3,000 to 4,000 in the USA. Although efforts are made to better understand and manage this disease, it is still associated with significant morbidity and mortality. Treatment options are limited to surgery for tumors with chemotherapy in case of malignant transformation. Our goal is to develop targeted pharmacological intervention for Neurofibromatosis type 1 related conditions.

“Our relationships with our patients are second to none.”

Next Lecture Series

Topic: HF10 Therapy and Recent Advances in Spinal Cord Stimulation
Speaker: Dr Leonardo Kapural
Date: Thursday, January 21, 2021 | 8:30am EST

Join Our Team

Be a part of the vision.


The staff is very professional. The building is nice and modern. Dr. Tarabishy is very understanding and cares about your well being!  -Deisheha
Dr. Shah saved my son’s life.  -Anonymous Reviewer
An amazing experience! The staff was so caring and understanding. Dr Tarabishy's patience and compassion helped me through my procedure. I'm so blessed to be their patient!  -Kevin